Response to: Correspondence on Bell's palsy as an adverse event following COVID-19 vaccination

Acta Neurol Belg. 2023 Dec;123(6):2417-2418. doi: 10.1007/s13760-023-02245-7. Epub 2023 Mar 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Bell Palsy* / drug therapy
  • Bell Palsy* / etiology
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Facial Paralysis*
  • Humans
  • Vaccination

Substances

  • Antiviral Agents
  • COVID-19 Vaccines